27463423|t|Impaired autophagy in macrophages promotes inflammatory eye disease
27463423|a|Autophagy is critical for maintaining cellular homeostasis. Organs such as the eye and brain are immunologically privileged. Here, we demonstrate that autophagy is essential for maintaining ocular immune privilege. Deletion of multiple autophagy genes in macrophages leads to an inflammation-mediated eye disease called uveitis that can cause blindness. Loss of autophagy activates inflammasome -mediated IL1B secretion that increases disease severity. Inhibition of caspase activity by gene deletion or pharmacological means completely reverses the disease phenotype. Of interest, experimental uveitis was also increased in a model of Crohn disease, a systemic autoimmune disease in which patients often develop uveitis, offering a potential mechanistic link between macrophage autophagy and systemic disease. These findings directly implicate the homeostatic process of autophagy in blinding eye disease and identify novel pathways for therapeutic intervention in uveitis.
27463423	0	8	Impaired	T169	C0221099
27463423	9	18	autophagy	T043	C0004391
27463423	22	33	macrophages	T025	C0024432
27463423	43	67	inflammatory eye disease	T047	C0042164
27463423	68	77	Autophagy	T043	C0004391
27463423	106	126	cellular homeostasis	T043	C2244223
27463423	128	134	Organs	T023	C0178784
27463423	147	150	eye	T023	C0015392
27463423	155	160	brain	T023	C0006104
27463423	165	180	immunologically	T169	C0205470
27463423	219	228	autophagy	T043	C0004391
27463423	258	264	ocular	T023	C0015392
27463423	265	271	immune	T169	C0439662
27463423	283	291	Deletion	T045	C0017260
27463423	295	303	multiple	T081	C0439064
27463423	304	313	autophagy	T043	C0004391
27463423	314	319	genes	T028	C0017337
27463423	323	334	macrophages	T025	C0024432
27463423	347	380	inflammation-mediated eye disease	T047	C0042164
27463423	388	395	uveitis	T047	C0042164
27463423	411	420	blindness	T033	C0456909
27463423	422	426	Loss	T081	C1517945
27463423	430	439	autophagy	T043	C0004391
27463423	440	449	activates	T052	C1879547
27463423	450	462	inflammasome	T116,T123	C2936529
27463423	473	477	IL1B	T116,T123	C1702300
27463423	478	487	secretion	T043	C1327616
27463423	503	519	disease severity	T080	C0521117
27463423	521	531	Inhibition	T052	C3463820
27463423	535	551	caspase activity	T044	C1150130
27463423	555	568	gene deletion	T045	C0017260
27463423	572	587	pharmacological	T169	C0205464
27463423	605	635	reverses the disease phenotype	T033	C4086829
27463423	650	662	experimental	T080	C1517586
27463423	663	670	uveitis	T047	C0042164
27463423	695	700	model	T170	C3161035
27463423	704	717	Crohn disease	T047	C0010346
27463423	721	729	systemic	T047	C0442893
27463423	730	748	autoimmune disease	T047	C0004364
27463423	758	766	patients	T101	C0030705
27463423	781	788	uveitis	T047	C0042164
27463423	836	846	macrophage	T025	C0024432
27463423	847	856	autophagy	T043	C0004391
27463423	861	877	systemic disease	T047	C0442893
27463423	917	936	homeostatic process	T038	C0019868
27463423	940	949	autophagy	T043	C0004391
27463423	953	961	blinding	T062	C0150108
27463423	962	973	eye disease	T047	C0015397
27463423	987	992	novel	T080	C0205314
27463423	993	1001	pathways	T077	C1705987
27463423	1006	1030	therapeutic intervention	T061	C0808232
27463423	1034	1041	uveitis	T047	C0042164